Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report
The non-Hodgkin’s lymphomas are a diverse group of lymphoid neoplasms that collectively rank fifth in cancer incidence and mortality. Patients treated with mediastinal radiotherapy and/or anthracycline-containing chemotherapy are known to have increased risks of coronary heart disease, valvular hear...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/4/489 |
_version_ | 1797445082025033728 |
---|---|
author | Diana Žaliaduonytė Rita Kleinauskienė Gintarė Muckienė Vytautas Zabiela |
author_facet | Diana Žaliaduonytė Rita Kleinauskienė Gintarė Muckienė Vytautas Zabiela |
author_sort | Diana Žaliaduonytė |
collection | DOAJ |
description | The non-Hodgkin’s lymphomas are a diverse group of lymphoid neoplasms that collectively rank fifth in cancer incidence and mortality. Patients treated with mediastinal radiotherapy and/or anthracycline-containing chemotherapy are known to have increased risks of coronary heart disease, valvular heart disease, and heart failure. This may be the result of cancer treatment cardiotoxicity or may be due to accelerated development of cardiovascular disease. We presented 41-year-old male who was admitted to the hospital because of congestive heart failure. He has a medical history of non-Hodgkin’s lymphoma treated with anthracycline-based chemotherapy and mediastinal radiotherapy almost 20 years ago. Echocardiography showed significant aortic valve stenosis, thickened and fibrotic pericardium. Coronary angiography showed diffuse three-vessel coronary artery disease. The patient was referred for surgical treatment. Aortic valve replacement, coronary artery bypass grafting and pericardiectomy were successfully performed, symptoms of heart failure reduced. |
first_indexed | 2024-03-09T13:20:37Z |
format | Article |
id | doaj.art-95cc17b3a0154c9c91fd237608a2a5f9 |
institution | Directory Open Access Journal |
issn | 1010-660X 1648-9144 |
language | English |
last_indexed | 2024-03-09T13:20:37Z |
publishDate | 2022-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Medicina |
spelling | doaj.art-95cc17b3a0154c9c91fd237608a2a5f92023-11-30T21:30:15ZengMDPI AGMedicina1010-660X1648-91442022-03-0158448910.3390/medicina58040489Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case ReportDiana Žaliaduonytė0Rita Kleinauskienė1Gintarė Muckienė2Vytautas Zabiela3Department of Cardiology, Medical Academy, Hospital of Lithuanian University of Health Sciences, Eivenių St. 2, 50161 Kaunas, LithuaniaDepartment of Cardiology, Medical Academy, Hospital of Lithuanian University of Health Sciences, Eivenių St. 2, 50161 Kaunas, LithuaniaDepartment of Cardiology, Medical Academy, Hospital of Lithuanian University of Health Sciences, Eivenių St. 2, 50161 Kaunas, LithuaniaDepartment of Cardiology, Medical Academy, Hospital of Lithuanian University of Health Sciences, Eivenių St. 2, 50161 Kaunas, LithuaniaThe non-Hodgkin’s lymphomas are a diverse group of lymphoid neoplasms that collectively rank fifth in cancer incidence and mortality. Patients treated with mediastinal radiotherapy and/or anthracycline-containing chemotherapy are known to have increased risks of coronary heart disease, valvular heart disease, and heart failure. This may be the result of cancer treatment cardiotoxicity or may be due to accelerated development of cardiovascular disease. We presented 41-year-old male who was admitted to the hospital because of congestive heart failure. He has a medical history of non-Hodgkin’s lymphoma treated with anthracycline-based chemotherapy and mediastinal radiotherapy almost 20 years ago. Echocardiography showed significant aortic valve stenosis, thickened and fibrotic pericardium. Coronary angiography showed diffuse three-vessel coronary artery disease. The patient was referred for surgical treatment. Aortic valve replacement, coronary artery bypass grafting and pericardiectomy were successfully performed, symptoms of heart failure reduced.https://www.mdpi.com/1648-9144/58/4/489aortic valve stenosiscoronary artery diseaseheart failurecardiotoxic treatment |
spellingShingle | Diana Žaliaduonytė Rita Kleinauskienė Gintarė Muckienė Vytautas Zabiela Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report Medicina aortic valve stenosis coronary artery disease heart failure cardiotoxic treatment |
title | Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report |
title_full | Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report |
title_fullStr | Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report |
title_full_unstemmed | Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report |
title_short | Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report |
title_sort | cardiovascular disorder after cardiotoxic non hodking s lymphoma treatment a case report |
topic | aortic valve stenosis coronary artery disease heart failure cardiotoxic treatment |
url | https://www.mdpi.com/1648-9144/58/4/489 |
work_keys_str_mv | AT dianazaliaduonyte cardiovasculardisorderaftercardiotoxicnonhodkingslymphomatreatmentacasereport AT ritakleinauskiene cardiovasculardisorderaftercardiotoxicnonhodkingslymphomatreatmentacasereport AT gintaremuckiene cardiovasculardisorderaftercardiotoxicnonhodkingslymphomatreatmentacasereport AT vytautaszabiela cardiovasculardisorderaftercardiotoxicnonhodkingslymphomatreatmentacasereport |